PMC:7105881 / 39579-40083
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id | tao:has_standard_notation |
|---|---|---|---|---|---|---|
| 1197 | 147-151 | Gene | denotes | ACE2 | Gene:59272 | |
| 1203 | 60-68 | Species | denotes | SARS-CoV | Tax:694009 | |
| 1204 | 387-395 | Species | denotes | SARS-CoV | Tax:694009 | |
| 1209 | 39-44 | Mutation | denotes | R441A | p.R441A |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T240 | 336-346 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
LitCovid_AGAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| p63110s15 | 69-78 | NegReg | denotes | disrupted |
| p63110s18 | 89-110 | MPA | denotes | neutralizing epitopes |
| p63110s21 | 115-151 | MPA | denotes | affinity to bind viral receptor ACE2 |
| p63110s29 | 158-168 | NegReg | denotes | abolishing |
| p63112s34 | 465-479 | MPA | denotes | immunogenicity |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T225 | 60-68 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T226 | 387-395 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T516 | 20-21 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T517 | 269-276 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animals |
| T518 | 323-324 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T519 | 359-360 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T249 | 336-346 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
| T250 | 336-341 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
| T251 | 342-346 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T75 | 361-374 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32265848-24355931-36511168 | 494-498 | 24355931 | denotes | 2014 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T227 | 11-296 | Sentence | denotes | Notably, a single mutation (R441A) in the RBD of SARS-CoV disrupted its major neutralizing epitopes and affinity to bind viral receptor ACE2, thus abolishing the vaccine’s immunogenicity, and hence, its ability to induce neutralizing antibodies in immunized animals (He et al., 2006b). |
| T228 | 297-500 | Sentence | denotes | Additionally, deletion of a particular amino acid by changing a glycosylation site in the SARS-CoV RBD (RBD219-N1) also resulted in the alteration of subunit vaccine’s immunogenicity (Chen et al., 2014). |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T708 | 60-68 | SP_10 | denotes | SARS-CoV |
| T709 | 102-110 | BV_9 | denotes | epitopes |
| T710 | 132-137 | NCBITaxon:10239 | denotes | viral |
| T711 | 147-151 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T712 | 183-197 | BV_15 | denotes | immunogenicity |
| T713 | 245-255 | GO:0042571 | denotes | antibodies |
| T714 | 269-276 | NCBITaxon:33208 | denotes | animals |
| T715 | 387-395 | SP_10 | denotes | SARS-CoV |
| T716 | 465-479 | BV_15 | denotes | immunogenicity |
| T88864 | 60-68 | SP_10 | denotes | SARS-CoV |
| T91081 | 102-110 | BV_9 | denotes | epitopes |
| T20227 | 132-137 | NCBITaxon:10239 | denotes | viral |
| T95863 | 147-151 | G_3;PG_10;PR:000003622 | denotes | ACE2 |
| T94059 | 183-197 | BV_15 | denotes | immunogenicity |
| T73841 | 245-255 | GO:0042571 | denotes | antibodies |
| T65342 | 269-276 | NCBITaxon:33208 | denotes | animals |
| T44219 | 387-395 | SP_10 | denotes | SARS-CoV |
| T65405 | 465-479 | BV_15 | denotes | immunogenicity |